Recently, Zhu et al. reported that fatostatin significantly suppresses the growth of transplanted B16 melanoma in mice by inhibiting SREBP-2-mediated lipid metabolism, particularly reducing cholesterol levels [86]. This evidence concerns the gene SREBF2 and melanoma.